COMP <GO>
MDXG vs TCMD // GROSS PROFIT MARGIN
MiMedx Group Inc (NASDAQ) VS. Tactile Systems Technology Inc. (NASDAQ) • 15-METRIC TALLY: MDXG 10
— TCMD 2
▲ GROSS PROFIT MARGIN LEADER: MDXG
LAST: $3.97 (+0.51%) • MKT CAP: $579.3M
gross-margins
82.60%
LAST: $24.31 (+1.67%) • MKT CAP: $550.7M
gross-margins
75.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MDXG VS. TCMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MDXG | TCMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 82.60% | 75.90% | +6.70 | MDXG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 47.20% | 17.10% | +30.10 | MDXG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.7x | 14.9x | -8.20 | MDXG | /valuation <GO> |
| Free Cash Flow Yield | 12.77% | 7.34% | +5.43 | MDXG | /fcf-yield <GO> |
| Operating Margin | 15.30% | 8.90% | +6.40 | MDXG | /operating-margins <GO> |
| Net Profit Margin | 11.60% | 5.80% | +5.80 | MDXG | /net-margins <GO> |
| Revenue Growth (YoY) | 20.00% | 12.50% | +7.50 | MDXG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.45 | 8.38 | -1.93 | TCMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | MDXG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.9 | 49.2 | -16.37 | TCMD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.0x | 24.3x | -14.30 | MDXG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $579.3M | $550.7M | $28.6M | MDXG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MDXG REV | TCMD REV | MDXG GROSS % | TCMD GROSS % | MDXG FCF | TCMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $418.6M | $329.5M | 82.6% | 75.9% | $74.0M | $40.4M |
| FY 2024 | $348.9M | $293.0M | 82.8% | 74.0% | $66.2M | $38.3M |
| FY 2023 | $321.5M | $274.4M | — | — | $26.8M | $35.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MDXG // BETA —
TCMD // BETA —